Indiana University School of Medicine Dermatology

Topics

• Psoriasis: Treatment and Pathogenesis 153
• Acne and Rosacea Treatments and Effects 146
• Dermatology and Skin Diseases 125
• Cutaneous Melanoma Detection and Management 77
• Nonmelanoma Skin Cancer Studies 64
• melanin and skin pigmentation 58
• Vascular Malformations and Hemangiomas 56
• Cancer and Skin Lesions 53
• Nail Diseases and Treatments 45
• Neurogenetic and Muscular Disorders Research 45
• Cutaneous lymphoproliferative disorders research 44
• Cervical Cancer and HPV Research 39

Most cited

1. Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).

   The British journal of dermatology · 2021 · 502 citations · Leon Kircik

2. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial.

   Journal of the American Academy of Dermatology · 2023 · 241 citations · Leon Kircik

3. Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 80 citations · Lawrence Mark

4. Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.

   The New England journal of medicine · 2022 · 220 citations · David Rosmarin

5. The psychological consequences of androgenetic alopecia: A systematic review.

   Journal of cosmetic dermatology · 2023 · 93 citations · Erica Aukerman

6. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations.

   Journal of the European Academy of Dermatology and Venereology : JEADV · 2023 · 111 citations ·